Results 121 to 130 of about 3,399 (216)

Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.

open access: yes, 2004
Fabry's disease is an X-linked lysosomal storage disease caused by a deficiency of alpha-galactosidase that results in an accumulation of neutral glycosphingolipids throughout the body, including the cardiovascular system.
Andreucci MV.   +8 more
core  

A 17-year-old boy with hemifacial flushing and anhidrosis. [PDF]

open access: yesJAAD Case Rep
Farinha PS   +3 more
europepmc   +1 more source

A classical variant of ectodermal dysplasia: a case report. [PDF]

open access: yesPan Afr Med J
Jawade S   +4 more
europepmc   +1 more source

A novel pathogenic mutation in TSPEAR associated with sensorineural hearing loss: a case report and review of the literature. [PDF]

open access: yesJ Med Case Rep
Ahmadkhani A   +5 more
europepmc   +1 more source

Cutaneous manifestations of Fabry disease: A systematic review. [PDF]

open access: yesJ Dermatol
Al-Chaer RN   +4 more
europepmc   +1 more source

Prenatal Identification of an EDA Variant in Dichorionic Male Twins: CfDNA Signal with Invasive Confirmation. [PDF]

open access: yesGenes (Basel)
Marcella S   +14 more
europepmc   +1 more source

Defining Histological Patterns in Inherited Ichthyoses: Toward a Diagnostic Algorithm Based on 66 Confirmed Cases. [PDF]

open access: yesDermatopathology (Basel)
Süßmuth K   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy